2014 Sponsors

News


UK & Ireland Prostate Brachytherapy Conference 2021 With regret, we have cancelled plans to run the May 2021 Conference. The Newcastle team had hoped the deferred meeting would go ahead, but we are still faced with a hugely uncertain situation regarding COVID-19.


 

 

 
 
 
 

2014 Conference Sponsors

 

Thank you to the following companies who sponsored the 2014 conference.

 

PLATINUM SPONSORS:

Accelyon Small LogoCommitted to the future of Brachytherapy

 

Accelyon is a company with an exclusive focus on prostate brachytherapy and a strong commitment to offering the very best products and services to centres in the UK, Ireland, Australia and New Zealand.

 

While the name might be new the Accelyon team has over 50 years‘ combined experience in brachytherapy. This experience has been pooled to create a company which puts excellence in the the delivery and development of this important treatment option at the centre of everything it does.

 

Accelyon is committed to keeping brachytherapy it’s priority in terms of strategy, funding, innovation, service and support.

 

For further information please contact: Accelyon Ltd, 268 Bath Road, Slough UK SL1 4DX

General Enquiries: 0800 0148060 Direct number: 0044 (0)1753 607410 or visit their website.

 

GOLD SPONSORS:

GE Healthcare LogoGE Healthcare Oncology - Solutions from screening to treatment monitoring. Enabling personalized cancer care.

 

Our mission is to help your oncology multidisciplinary team improve the cancer patient care by providing essential components you need for an overall quality cancer management. Visit their website for more information.

SILVER SPONSORS:

Astellas Oncology logo

ASTELLAS PHARMA CO.,LTD
Astellas is a global manufacturing company, headquartered in Japan and with major manufacturing sites located in Dublin and in Killorglin Co. Kerry. Our product range focuses on the key therapy areas of Urology, Transplantation, Pain Management, Dermatology, Anti-Infectives and Oncology.

 

5 Waterside, Citywest Business Campus, Citywest, Dublin 24. ( 01 4671555 7 01 4671550).


Visit their website for more information.

BARD logo

BARD is a leader in products that focus on Disease State Management in three key areas: Vascular, Urology, and Oncology.

 

In the specialized field of prostate cancer, our Brachytherapy business unit offers urologists, radiologists, oncologists and physicists a "Total Resource" for the diagnosis and treatment of prostate cancer.


Visit their website for more information.

Bayer Healthcare logo

BAYER HEALTHCARE - Innovation for better health. At Bayer our commitment is to bring to patients around the world quality medicines for use in diagnosing, combating and preventing disease. Every day we work against time, researching new pathways, new molecules, new technologies – complementing our own capabilities with expertise of innovative partners from science and industry.

 

The success of this work is evidenced in new medicines for areas with significant unmet medical need such as oncology, cardiovascular and blood diseases, as well as gyneacology and ophthalmology. Our aim is a better quality of life for all.


Visit their website for more information.

Eckert and Ziegler Bebig logo

Eckert & Ziegler Bebig are active in the health care sector and specialize on cancer treatment by radiation technology. They focus on cancer treatment by brachytherapy, using implants, plaques or catheters containing minuscule quantities of a radioisotope.

 

So far, they have developed Iodine-125 implants against prostate cancer, Ruthenium-106 eye applicators and Iodine-125 ophthalmic seeds for eye cancer treatment and HDR afterloaders using applicators and catheters for a number of different applications.

 

Visit www.bebig.eu for more information.

Elekta logo

Elekta Brachytherapy is a growing treatment modality and is commonly used for many indications such as gynecology, prostate, breast, head & neck, skin and rectal. Brachytherapy is suited as a single modality or in combination with other treatments. For example, early stage prostate cancer can be indicated for brachytherapy as a single modality or as a boost after external beam radiation therapy for gynecological cancers.

 

With more than 35 years of experience, Nucletron, an Elekta company, can offer you a complete range of brachytherapy solutions supporting your brachytherapy practice. Our key technological advances have resulted in an integrated package of treatment planning and delivery systems. We believe that our solutions, services and extensive knowledge of precisely targeted brachytherapy can play a vital role in treating cancer successfully.


Visit their website for more information.

MIM Software logo

MIM Software Inc. provides practical imaging solutions in the fields of radiation oncology, radiology, nuclear medicine, neuroimaging, and cardiac imaging. MIM offers solutions for PC and Mac® workstations, as well as mobile iOS and cloud-based platforms. MIM is a privately held company that sells its products globally to imaging centers, hospitals, specialty clinics, research organizations, and pharmaceutical companies.

 

MIM Symphony™ is an exciting new collaborative platform for prostate cancer diagnosis and management. With no compromise solutions for radiology and urology, both disciplines are able to focus on their specialties while providing each other a wealth of information for accurate diagnosis and staging.


Visit their website for more information.

Takeda logo

Based on the corporate philosophy of "Takeda-ism" (Integrity: Fairness, Honesty and Perseverance) developed over its long corporate history of more than 230 years, Takeda conducts activities according to the corporate mission to “strive towards better health for people worldwide through leading innovation in medicine.”

 

Takeda UK is a wholly owned subsidiary of Japan's leading pharmaceutical company. Building on a distinguished 230-year heritage, Takeda today is the world’s 12th largest manufacturer of ethical medicines, a research-based global enterprise with affiliates in 71 countries and employing some 31,000 people.


Visit their website for more information.